SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-20-000781
Filing Date
2020-03-12
Accepted
2020-03-12 16:06:22
Documents
51
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cns_10k-123119.htm 10-K 614908
2 PATENT AND TECHNOLOGY LICENSE AGREEMENT cns_ex1011.htm EX-10.11 186698
9 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY cns_ex1012.htm EX-10.12 12152
10 CERTIFICATION cns_ex3101.htm EX-31.1 9709
11 CERTIFICATION cns_ex3102.htm EX-31.2 9543
12 CERTIFICATIONR cns_ex3201.htm EX-32.1 3495
13 CERTIFICATION cns_ex3202.htm EX-32.2 3683
  Complete submission text file 0001683168-20-000781.txt   3064924

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cnsp-20191231.xsd EX-101.SCH 30281
4 XBRL INSTANCE FILE cnsp-20191231.xml EX-101.INS 384479
5 XBRL CALCULATION FILE cnsp-20191231_cal.xml EX-101.CAL 41120
6 XBRL DEFINITION FILE cnsp-20191231_def.xml EX-101.DEF 132084
7 XBRL LABEL FILE cnsp-20191231_lab.xml EX-101.LAB 252405
8 XBRL PRESENTATION FILE cnsp-20191231_pre.xml EX-101.PRE 207684
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39126 | Film No.: 20708787
SIC: 2834 Pharmaceutical Preparations